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Contribution of the intramolecular disulfide bridge to the folding
stability of REIv, the variable domain of a human
immunoglobulin  light chain
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Background: Immunoglobulin domains contain about 100 amino acid residues
folded into two -sheets and stabilized in a sandwich by a conserved central
disulfide bridge. Whether antibodies actually require disulfide bonds for stability
has long been a matter of debate. The contribution made by the central disulfide
bridge to the overall folding stability of the immunoglobulin REIv, the variable
domain of a human  light chain, was investigated by introducing stabilizing
amino acid replacements followed by removal of the disulfide bridge via chemical
reduction or genetic substitution of the cysteine residues. 
Results: Nine REIv variants were constructed by methods of protein engineering
that have folding stabilities elevated relative to wild-type REIv by (up to)
16.0 kJ mol–1. Eight of these variants can be cooperatively refolded after
unfolding and chemical reduction of the disulfide bridge — in contrast to wild-
type REIv. The stabilizing effect of one of these residue replacements (T39K) was
rationalized by determining the structure of the respective REIv variant at 1.7 Å.
The loss of folding stability caused by reduction of the intramolecular disulfide
bond is on average 19 kJ mol–1. Removal of the disulfide bridge by genetic
substitution of C23 for valine resulted in a stable immunoglobulin domain in the
context of the stabilizing Y32H amino acid exchange; again, REIv-C23V/Y32H
has 18 kJ mol–1 less folding stability than REIv-Y32H. The data are consistent
with the notion that all variants studied have the same overall three-dimensional
structure with the disulfide bridge opened or closed. 
Conclusions: A comparison of the magnitude of the stabilizing effect exerted by
the disulfide bond and the length of the mainchain loop framed by it suggests
lowering of the entropy of the unfolded state as the sole source of the effect.
Disulfide bonds are not necessary for proper folding of immunoglobulin variable
domains and can be removed, provided the loss of folding stability is at least
partly compensated by stabilizing amino acid exchanges. 
Introduction
Members of the immunoglobulin gene superfamily
encode proteins that are entirely or partly made up of
domains possessing the immunoglobulin fold [1]. Each of
these is a sandwich of two antiparallel -sheets [2] linked
by a disulfide bridge which is buried in the hydrophobic
interior of the domain. The structure of immunoglobulin
variable domains (Fig. 1) is not entirely determined by
germline DNA sequence, but results in part from an inter-
play of random processes and functional selection during
the ontogeny of each individual organism. This means
that the invariant core of the domain must provide a
general and versatile scaffold, compatible with a variety of
different surface loops, an aspect that is accentuated in the
context of recent efforts to construct antibodies with pre-
determined functions without resorting to the evolution-
ary mechanisms inherent in the immune system of a
higher vertebrate [3].
In view of their obvious importance for many aspects of
antibody engineering, surprisingly little is known about
the folding stability and folding kinetics of immunoglob-
ulin variable domains. Earlier work, focussing mainly on
entire light chains and CL domains, showed that
immunoglobulins have a rather low folding stability of
typically around 25 kJ mol–1 [4,5]. The study presented
here was carried out to further our knowledge of VL
domain folding; specifically, it addresses the issue of
what contribution to folding stability is made by the
highly conserved disulfide bridge (for review, see [6]).
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The most straightforward approach to this problem
would build upon quantitative measurements of folding
stabilities of immunoglobulin variable domains with
disulfide bridges either chemically reduced or abolished
by genetic amino acid replacement. This seemed to be
precluded, however, since loss of the disulfide bridge is
normally accompanied by total loss of ordered folding
[7].
Recently, we have circumvented this problem by engi-
neering a single stabilizing amino acid exchange (Y32H; in
the one-letter amino acid code) into the human  variable
domain REIv, which endowed it with enough additional
folding stability to escape collapse of the immunoglobulin
fold upon subsequent removal of the disulfide bridge [8].
In the study presented here, we have performed a system-
atic search for additional stabilizing amino acid exchanges,
aimed at producing hyperstable REIv variants that no
longer require disulfide bond formation for establishing
their native fold. This type of variant not only makes pos-
sible the quantitative assessment of the contribution the
disulfide bridge makes to folding stability, but also opens
new possibilities in antibody engineering, such as the
accumulation of soluble immunoglobulin (fragments) in
the reducing environment of the Escherichia coli cytoplas-
mic compartment.
Results
Identification of amino acid exchanges with a potentially
stabilizing effect
Amino acid exchange Y32H [8] was found serendipitously
to stabilize the REIv domain by ~ 5.6 kJ mol–1 (Table 1).
This stabilizing effect is possibly due to hydrogen bonds
and/or a salt bridge of the imidazole sidechain of H32 with
the sidechains of Q92 of CDR3 and/or, respectively, E50
of CDR2. 
Amino acid substitutions T39K, Y71F and F73L were
chosen as likely candidates to stabilize the REIv domain
on the basis of the statistical underrepresentation of threo-
nine at position #39, tyrosine at position #71 and pheny-
lalanine at position #73 in a database of 116
immunoglobulin  light chains most similar to REIv ([9];
A Reinhardt, unpublished data). Most strikingly, residue
#71 is a tyrosine in REIv; multiple sequence alignment of
the above human  light chain family, however, revealed
the presence of a phenylalanine residue at this position in
111 of 116 cases. A similar bias was found for lysine at
position #39 (104 of 116 cases) and for leucine at position
#73 (104 of 116 cases).
Substitutions Y71F and F73L have been designed solely
on the basis of the working hypothesis that amino acid
replacements in REIv towards a canonical immunoglobu-
lin sequence [9] lead to protein stabilization. Inspection of
the chemical environment of these residues at positions
#71 and #73 in REIv, which contribute to the hydrophobic
core of the protein, did not reveal an obvious gain in
folding stability by introducing the preferred residues
phenylalanine and leucine.
On the other hand, the potentially stabilizing effect of the
T39K mutation could be rationalized by comparing the
structural environment of REIv T39 with K45 of antibody
McPC603 (position #45 in McPC603 is structurally homol-
ogous to position #39 of REIv). REIv residue #39 and
McPC603 residue #45 have nearly identical chemical
environments. The K45 -amino group in the McPC603
VL domain resides in a surrounding of negative electrosta-
tic potential provided by a glutamate (#87) and an aspar-
tate (#88) residue and forms, in addition, a hydrogen bond
to the mainchain carbonyl oxygen of residue #87. The
same favorable interactions would be possible if T39 of
REIv were replaced by lysine. 
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Figure 1
C trace of wild-type REIv. The sidechains of residues W35 (the
fluorescent reporter group of reversible unfolding), C23 and C88
(which form the central disulfide bridge), Y32, T39, Y71 and F73 (sites
of the stabilizing amino acid exchanges Y32H, T39K, Y71F and F73L)
are drawn in a ball-and-stick representation. Note that amino acid
residues #32, #39, #71 and #73 are located remote from W35, the
fluorescent reporter group. The picture was prepared with the
MOLSCRIPT program [37].
T39
C23
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Construction and production of REIv variants
REIv variants (Table 1) carrying the potentially stabilizing
mutations Y32H, T39K, Y71F, F73L and combinations
with two or three simultaneous residue replacements were
constructed by directed mutagenesis of the rei structural
gene present in phagemid pHKREI [10]. The various
REIv proteins were produced as -lactamase/REIv
chimeras via protein accumulation in the periplasmic
space of E. coli [10].
In addition, several REIv derivatives were constructed and
produced in which the central disulfide bridge was abol-
ished genetically by substitution of one or both cysteines
for valine. None of the REIv variants C23V, C23V/T39K
or C23V/Y32H/T39K/C88V could be purified in amounts
sufficient for physicochemical characterization. In con-
trast, variant C23V/Y32H led to a stable disulfide-free
protein when produced via secretion of the -
lactamase/REIv-C23V/Y32H fusion protein into the E. coli
periplasm. Furthermore, this variant could also be isolated
in soluble form via accumulation in the cytoplasmic com-
partment. This way, about 1 mg of pure REIv-C23V/Y32H
was obtained from one liter of bacterial liquid culture [8].
A direct correlation was observed between the folding sta-
bilities of different REIv variants (Table 1) and their net
accumulation in the periplasmic space of E. coli. This is
illustrated for several REIv variants in Figure 2. For REIv
variants with lower folding stability (e.g. REIv-
C23V/Y32H), a proteolytic degradation product of the
respective -lactamase/REIv fusion protein is seen in
western blots (Fig. 2), the amount of which increases con-
comitantly with the decrease of the uncleaved -lacta-
mase/REIv fusion protein. Since this putative degradation
product has a significantly higher apparent molecular
weight than -lactamase (Mr 29 000), it probably corre-
sponds to a fusion protein consisting of -lactamase and a
carboxy-terminal truncated REIv domain. Hence, the dif-
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Table 1
Changes in the free energies of unfolding upon mutation or addition of DTT compared to the wild-type and the respective disulfide
form, determined by equilibrium denaturation.*
GU[urea]1/2 ‡ GU[urea]1/2 ‡
Number of m [urea]1/2 GU[urea]1/2 † (relative to wild- (relative to disulfide
REIv variant measurements (kJ mol–1 M–1) (M) (kJ mol–1) type) (kJ mol–1) form) (kJ mol–1)
Wild-typeSS 7 7.04 (±0.19) 3.74 (±0.02) 24.6 (±0.4)
T39KSS 5 6.69 (±0.26) 4.55 (±0.02) 29.9 (±0.5) –5.3 (±0.6)
T39K(SH)2 3 7.17 (±0.42) 1.63 (±0.10) 12.1 (±0.9) 12.5 (±1.0) 17.8 (±1.0)
Y32HSS 3 6.75 (±0.37) 4.59 (±0.02) 30.2 (±0.5) –5.6 (±0.6)
Y32H(SH)2 1 8.37 (±1.52) 1.58 (±0.17) 11.7 (±1.3) 12.9 (±1.4) 18.5 (±1.4)
F73LSS 3 5.33 (±0.15) 4.38 (±0.01) 28.7 (±0.5) –4.1 (±0.6)
Y71FSS 3 5.99 (±0.28) 4.57 (±0.03) 30.0 (±0.5) –5.4 (±0.7)
Y71F(SH)2 3 6.18 (±0.36) 1.55 (±0.23) 11.5 (±1.8) 13.1 (±1.7) 18.5 (±1.9)
Y32H/T39KSS 3 5.81 (±0.32) 5.40 (±0.05) 35.5 (±0.6) –10.9 (±0.7)
Y32H/T39K(SH)2 1 7.59 (±0.48) 2.34 (±0.03) 17.4 (±0.8) 7.2 (±0.9) 18.1 (±1.0)
T39K/Y71FSS 3 6.23 (±0.25) 5.48 (±0.03) 36.0 (±0.6) –11.4 (±0.7)
T39K/Y71F(SH)2 3 8.20 (±0.67) 2.46 (±0.06) 18.3 (±0.9) 6.3 (±1.0) 17.7 (±1.1)
T39K/F73LSS 3 5.64 (±0.49) 5.17 (±0.08) 34.0 (±0.8) –9.4 (±0.9)
T39K/F73L(SH)2 3 8.55 (±0.96) 1.97 (±0.09) 14.6 (±0.9) 10.0 (±1.0) 19.4 (±1.2)
Y71F/F73LSS 3 6.12 (±0.19) 5.25 (±0.12) 34.5 (±1.0) –9.9 (±1.0)
Y71F/F73L(SH)2 4 8.21 (±1.02) 1.91 (±0.1) 14.2 (±0.9) 10.4 (±1.0) 20.3 (±1.3)
T39K/Y71F/F73LSS 3 6.20 (±0.04) 6.18 (±0.01) 40.6 (±0.7) –16.0 (±0.8)
T39K/Y71F/F73L(SH)2 4 5.99 (±0.47) 2.41 (±0.09) 17.9 (±1.0) 6.7 (±1.1) 22.7 (±1.2)
C23V/Y32H 2 6.98 (±0.03) 1.93 (±0.03) 12.6 (±0.5) 12.0 (±0.6)
C23V/Y32H/T39K 4 6.27 (±0.22) 2.08 (±0.06) 13.5 (±0.6) 11.1 (±0.7)
*Standard errors of the data are given in parentheses. †Calculated from
the equation GU[urea]1/2 = 〈m〉 [urea]1/2. ‡Calculated from equation 2
or 3 (see Materials and methods). Superscript SS represents an intact
disulfide bridge, superscript (SH)2 the reduced form thereof.
ferences in net accumulation are apparently due to differ-
ent turnover rates of the REIv variants, controlled by their
differential susceptibility to cleavage by periplasmic pro-
teases.
Evidence for very similar tertiary structures of the various
REIv proteins
We have evidence from crystal structure determination,
CD spectroscopy, gel filtration chromatography studies,
and reversible unfolding that the various REIv variants
with and without a disulfide bridge display a very similar
tertiary fold.
To investigate the structural changes resulting from the
T39K exchange in REIv and, secondly, to determine the
structural basis of the stabilizing effect of the T39K muta-
tion, we crystallized the T39K variant and determined its
structure to a resolution of 1.7 Å (Fig. 3; I Usón et al.,
unpublished data). These data show that the backbone
structure of REIv-T39K is nearly identical to that in wild-
type REIv with a root-mean-square deviation of 0.35 Å. As
predicted, the residues in the immediate environment of
the T39K mutation quite closely resemble those found in
McPC603. It is very likely that the stabilizing effect of the
T39K mutation is due to the additional hydrogen bond of
the -amino group of K39 with the carbonyl group of E81.
Figure 4 shows the circular dichroism (CD) spectra of
native (0 M urea) and denatured (8 M urea) wild-type
REIv, REIv-Y32H and REIv-C23V/Y32H/T39K. All CD
spectra of the native proteins have a maximum around
198 nm and a minimum around 218 nm, indicative of -
sheet structures [11]. The spectrum of REIv-
C23V/Y32H/T39K is only slightly shifted to shorter
wavelength. This indicates that the -sheet content of the
REIv variants with a disulfide bridge is similar to that of
the disulfide-free REIv variant. The CD spectra of the
proteins taken in the presence of 8 M urea were practically
identical in the region 208–260 nm and were typical for a
random coil [11].
Homodimerization of REIv is brought about by an intricate
network of interactions along the contact area [12] and it is
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Figure 3
#39
#81
#39
#81
(a) (b)
(a) Sigma a electron density map at the T39K mutation site. Map
calculated with O [38]. The hydrogen bond of the K39 -amino group
to the carbonyl oxygen of residue #81 is indicated by a dashed line.
(b) C least-squares superposition between the structures of wild-type
REIv (thin lines) and the T39K mutant (thick lines) for the mutation site
and its environment. Calculated with O [38].
Figure 2
Production of various REIv variants as -lactamase/REIv fusion
proteins. Western blot of fractions of soluble periplasmic proteins
isolated from E. coli strain KS474 [36] harboring different pHKREI
phagemids. The proteins were electrophorezed on a 15% SDS-
polyacrylamide gel. A polyclonal rabbit antiserum against -lactamase
was used for immunospecific detection of the -lactamase/REIv fusion
proteins. Lane 1, pHKREI; lane 2, pHKREI-Y32H; lane 3, pHKREI-
T39K; lane 4, pHKREI-Y32H/T39K; lane 5, pHKREI-C23V; lane 6,
pHKREI-C23V/T39K; lane 7, pHKREI-C23V/Y32H; lane 8, pHKREI-
C23V/Y32H/T39K; lane 9, pHKREI-C23V/Y32H/T39K/C88V; M,
marker proteins (Poinceau S staining, pencil marked) with relative
molecular masses (× 103) as indicated.
1 2 3 4 5 6 7 8 9 M
45
31
therefore to be expected that the monomer/dimer equilib-
rium would respond in a rather sensitive way to changes of
tertiary structure. Previously, we have used gel filtration
chromatography to study the dimerization equilibrium of
REIv and two variants, S67H and L94H, the latter of which
showed an increased association constant [13]. In this
study, the concentration-dependent molecular mass distri-
bution of REIv variants was examined by gel filtration on a
Superose 12 column via measurement of the elution
volume at different protein concentrations (Fig. 5). As the
monomer/dimer equilibrium formation of REIv is fast com-
pared to the migration velocity through the gel matrix, the
apparent elution volume corresponds directly to the equi-
librium distribution between the monomeric and the
dimeric state. Hence, identical concentration-dependent
elution from the gel filtration column for a REIv variant
compared to the wild-type indicates unchanged dimeriza-
tion behavior and a largely unchanged tertiary fold.
All REIv variants for which the monomer/dimer equilib-
rium was investigated display either wild-type-like associ-
ation behavior or that of the REIv-L94H variant. Most
importantly, the disulfide-free variant REIv-
C23V/Y32H/T39K exhibits wild-type-like association.
Energetic effects of removal of the disulfide bridge
Folding stabilities of REIv variants were determined by
urea-induced reversible unfolding [8,13]. As can be seen
from Table 1, all amino acid exchanges Y32H, T39K,
Y71F and F73L were found to stabilize the REIv protein,
by 5.6 kJ mol–1, 5.3 kJ mol–1, 5.4 kJ mol–1, and
4.1 kJ mol–1, respectively. The effects of these substitu-
tions on folding stability were roughly additive. This addi-
tivity is not surprising, because the residues in positions
#32, #39, #71 and #73 are remote from each other [14].
Folding stabilities for these REIv variants were also deter-
mined in the reduced state by equilibrium denaturation in
the presence of DTT, monitored by the change in trypto-
phan fluorescence concomitant with the transition from
the native to the denatured state of the protein [8,13].
Wavelengths of emission maxima (max) of the native and,
respectively, the denatured state of disulfide-containing
REIv variants were identical to those of disulfide-free vari-
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Figure 4
Far UV CD spectra of different REIv variants measured at 0 M urea
(native) and 8 M urea (denatured). Protein concentrations were
~ 40 M for measurements of native proteins and ~ 20 M for
measurements of denatured proteins in 0.01 M potassium phosphate
(pH 7.5). Solid line, wild-type REIv; dashed line, REIv-Y32H; dotted
line, REIv-C23V/Y32H/T39K.
Θ
Wavelength (nm)
190 200 210 220 230 240 250 260
-6
-4
-2
0
2
4
6
8 M urea
0 M urea
[ 
  ]
M
R
W
x 
10
-3
(d
eg
cm
2
d
m
o
l-1
)
Figure 5
Small zone gel filtration chromatography of REIv variants at different
protein concentrations. Measurements were performed using a
Superose 12 column (10 × 300 mm) with a flow rate of 0.5 ml min–1
at 4°C with 20 mM potassium phosphate (pH 7.0), 0.1 M NaCl as
running buffer. Kp values were determined as Kp = (Ve–V0)/(Vt–V0)
[13] and data for wild-type REIv and REIv-L94H were taken from this
reference.
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ants [8]. The change in tryptophan fluorescence intensity
was reversed, however. In disulfide-containing REIv vari-
ants, it increases upon denaturation, a behavior reversed
upon removal of the disulfide bridge (Fig. 6a,b). The
same effect of increased fluorescence quench in the oxi-
dized state of folded immunoglobulin was also observed
earlier with an immunoglobulin CL domain [5].
Cooperativities of reversible unfolding are nearly identical
for all REIv variants (Fig. 6c), a finding compatible with
similar modes of folding of all REIv forms tested. For the
REIv variants with a reduced disulfide bridge, slope m is
consistently higher than for the other REIv variants
(Fig. 6d; Table 1). The m value correlates positively to the
additional amount of protein surface exposed to solvent
upon unfolding [15]. The solvent-accessible surface of the
denatured state of a protein containing intramolecular
disulfide bonds is usually lower than that of the reduced
form. Consequently, a lower m value can be expected for
disulfide-bonded REIv variants compared to the disulfide-
free REIv derivatives.
The loss of folding stability upon reduction of the disul-
fide bridge was found to be in the range 18–23 kJ mol–1 for
all variants with single or multiple stabilizing amino acid
exchanges (Fig. 7; Table 1). For wild-type REIv and
REIv-F73L, the folding stabilities could not be measured
after removal of the intramolecular disulfide bridge by
chemical reduction (addition of DTT). The refolding
curves could not be interpreted quantitatively due to the
lack of asymptotic approach to a straight line at low con-
centration of denaturant (data not shown). For wild-type
REIv, this is not surprising in view of the fact that an
assumed loss of 19 kJ mol–1 would leave only ~ 6 kJ mol–1
of total folding stability to its reduced form and hence lead
to an equilibrium of 9% denatured form in the complete
absence of denaturant at 25°C. The stability of REIv-
F73LSS might be lower than the one calculated using the
average m value, because its m value is the lowest of all
REIv variants measured (Table 1). This would explain the
low stability of its reduced form. The reason for the lower
m value of REIv-F73LSS is not clear. There is no equilib-
rium intermediate visible in the urea denaturation curve
(data not shown). The effect on the m value seems to be
less pronounced in the two double mutants and the triple
mutant that carry the F73L exchange (Table 1). 
As can be seen from Figure 7, the stabilizations brought
about by single and combined amino acid substitutions
T39K, Y32H, Y71F and F73L do not change quantita-
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Figure 6
Urea-induced reversible unfolding of different
REIv variants with and without a disulfide
bridge. Protein concentrations were ~ 1 M.
(a) Fluorescence intensities of wild-type REIv
(circles) and REIv-Y32H/T39KSS (squares) at
given concentrations of urea. The emission
was measured at 350 nm (with Ex =
295 nm). (b) Fluorescence intensities of REIv-
C23V/Y32H/T39K (triangles) and REIv-
Y32H/T39K(SH)2 (squares) at given
concentrations of urea. The emission was
measured at 330 nm (with Ex = 280 nm). 
(c) Fraction of unfolded protein versus
concentration of urea for the REIv variants
shown in the upper panels, using the same
symbols. (d) Free energy of unfolding as a
function of urea concentration for the REIv
variants shown in the upper panels, using the
same symbols. Superscript SS represents an
intact disulfide bridge, superscript (SH)2 the
reduced form thereof.
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tively when going from the oxidized to the reduced form
of the respective REIv variants; furthermore, they are
additive in both series (Table 1). Again, this finding is
compatible with the notion that these substitutions do not
alter the global structure of the domain. The situation is
somewhat different for the REIv-Y32H variant with the
C23 residue replaced by valine. Here, the additional intro-
duction of the T39K exchange apparently fails to stabilize
the disulfide-free domain.
Discussion
The conserved intramolecular disulfide bridge is one of
the main structural features of the immunoglobulin fold.
Recently, we introduced a two-step approach to the con-
struction of immunoglobulins devoid of disulfide bonds.
This consists of first stabilizing the protein by amino acid
exchange, followed by removal of the disulfide bridge [8].
REIv, the variable domain of a human  light chain [12],
requires ~ 5 kJ mol–1 additional folding stability for
removal of the disulfide bridge without concomitant col-
lapse of the ordered fold. This can be achieved by intro-
duction of a single stabilizing mutation.
Amino acid exchanges Y32H, T39K, Y71F and F73L add
5.6 kJ mol–1, 5.3 kJ mol–1, 5.4 kJ mol–1, and 4.1 kJ mol–1,
respectively, to the conformational stability of REIv,
bringing it to 30 kJ mol–1 for the single mutants, to
35 kJ mol–1 for the double mutants and to 41 kJ mol–1 for
the triple mutant REIv-T39K/Y71F/F73L. The differ-
ences between the values of the free energies of unfolding
and the GU values reported here and by Frisch et al. [8]
arise from the different modes of data processing. In the
latter, GUH2O values were calculated individually and
GUH2O was calculated as GUH2O = GUH2O –
G′UH2O. The differences between the values are only
marginal, however, confirming the validity of the calcula-
tions presented here. 
Removal of the disulfide bridge by chemical reduction
destabilizes the domain by ~ 19 kJ mol–1; this value is the
same within experimental error for seven out of eight vari-
ants investigated (T39K/Y71F/F73L is slightly higher).
The destabilization of the VL domain REIv upon reduc-
tion is in the same range as that found for an immunoglob-
ulin CL domain. Goto and co-workers [5,16] calculated a
GU of ~ 16.7 kJ mol–1 (4.0 kcal mol–1) between the
native and the reduced form of a CL domain isolated from
a type  Bence–Jones protein, and a GU of
~ 19.7 kJ mol–1 (4.7 kcal mol–1) between the native and
the reduced form of a CL domain isolated from a type 
Bence–Jones protein.
If the disulfide bridge is removed genetically by the
C23V amino acid exchange, the outcome is similar, albeit
not identical. In this background, introduction of the
amino acid exchange T39K has no stabilizing effect; the
triple mutant REIv-C23V/Y32H/T39K is only marginally
more stable than double mutant REIv-C23V/Y32H and,
furthermore, double mutant REIv-C23V/T39K, in con-
trast to double mutant REIv-C23V/Y32H, is too unstable
to be isolated in reasonable yield (Fig. 2). This is in con-
trast to the series of experiments with chemical reduc-
tion of the disulfide bond (see previous paragraph) in
which all energetic effects are additive, a finding that
would be expected if all molecular species tested had
very similar three-dimensional structures. The lack of a
stabilizing effect of the T39K substitution on REIv-
C23V may result from a slight distortion of the REIv ter-
tiary fold upon C23V substitution, abolishing part of the
stabilizing contacts K39 makes to its packing neighbors;
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Figure 7
Change of folding stabilities of REIv variants
upon addition of DTT. Open bars represent
folding stabilities measured from reversible
unfolding in the absence of DTT and filled
bars represent folding stabilities measured
from refolding in the presence of 50 mM DTT
after urea-induced denaturation in the
presence of 50 mM DTT (see Materials and
methods). Standard errors are indicated by
error bars.
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the hydrogen bond of the lysine -amino group to the
carbonyl oxygen of residue #81 being a plausible candi-
date (Fig. 3). In addition, variant REIv-
C23V/Y32H/T39K displays a slightly different
dimerization behavior compared to REIv-Y32H/T39K
(see Fig. 5), which may be taken as supportive evidence
for the assumption of not ideally identical structures.
Also, both variants containing the C23V exchange
display lower m values than the REIv variants with the
disulfide bond reduced. This could plausibly be due to
differences in the solvent-accessible area of the folded
form of the C23V variants compared to REIv(SH)2, lending
further support to structural differences between the
REIv variants with genetically and chemically removed
disulfide bonds.
Possible slight structural distortions of the REIv-C23V
variants notwithstanding, support for the notion of at least
quite similar tertiary folds of all REIv variants tested
comes from several independent lines of evidence. First,
although the fluorescence intensities of the native state of
REIv variants with disulfide bridges are much lower than
of those without, the wavelengths of their emission
maxima are identical in the native and, respectively, in the
denatured state [8]. This indicates that only the quench-
ing effect is removed by reduction or genetic removal of
the disulfide bridge [17] with no accompanying major con-
formational change [5,18]. Second, cooperativities of
reversible unfolding are similar for wild-type and mutant
REIv proteins, a finding at least not in conflict with the
above notion. Third, the CD spectra of native proteins of
REIv, REIv-Y32H and the disulfide-free variant REIv-
C23V/Y32H/T39K indicate the same amount of -sheet
conformation. Fourth, the REIv variants with the C23V
amino acid substitution exhibit homodimerization behav-
ior similar to REIv, suggesting the formation of a native
wild-type-like dimerization interface. While amino acid
exchange T39K has no effect on homodimerization, sub-
stitution Y32H unexpectedly leads to a slightly stronger
and possibly different mode of association; at present, we
cannot exclude formation of higher oligomers for REIv-
Y32H.
As illustrated above, the expected folding stability of
reduced REIv is no more than 6 kJ mol–1, which is clearly
too little to keep the protein in the native folding state in
equilibrium at body temperature. Therefore, there is no
need to consider, in addition to thermodynamic effects,
the hypothesis of disulfide formation being necessary
early in biosynthesis in order to make the native state
kinetically accessible [7]. Indeed, we could show that sta-
bilized variants of REIv can be renatured with the disul-
fide bridge reduced. It seems likely that the above
argument holds generally for a wide variety of
immunoglobulins, since other members were found to
have folding stabilities similar to that of REIv [4,5].
The contribution the disulfide bridge makes to the free
energy of folding could be of either enthalpic or entropic
nature (for review, see [19]). Additional experiments such
as reversible thermal unfolding [20,21] would be required
to distinguish unambiguously between these two possibil-
ities; the following argument, however, favors a largely
entropic effect. The gain of conformational entropy of the
denatured state upon reduction of the disulfide bond
depends on the loop length between the two cysteines
[22]. Estimation of conformational entropy using the
equation Sconf = 2.1 – (3/2)Rln n, where n is the number
of residues within the loop [22], provides a TS value for
REIv of 18.2 kJ mol–1 at 25°C, in good accord with the
experimentally determined value for GU of 19.1 (± 0.6)
kJ mol–1. This view has also gained experimental support
from the detailed kinetic analysis of the folding reaction of
a CL domain [23]. In addition, our observation that the
presence of the disulfide bridge in REIv leads to an accel-
eration of the folding process (C Frisch, unpublished data)
can also be explained in terms of the decreased entropy in
the unfolded state of the disulfide-containing
immunoglobulin.
Double mutant REIv-C23V/Y32H is a first example of a
stable immunoglobulin domain deprived of its disulfide
bridge by protein engineering [8]. While substitution of
C23 by valine has resulted in a moderately stable REIv
variant, introduction of valine for the other cysteine (C88)
led to a severe destabilization (see Fig. 2); the reason for
the observed asymmetry of effects is not immediately
obvious. Introduction of additional stabilizing amino acid
exchanges and systematic exploration of different residue
#23–#88 pairs may be useful in the development of com-
pletely cysteine-free immunoglobulin domains with wild-
type folding stabilities. REIv-C23V/Y32H can be
accumulated in the cytoplasmic compartment of E. coli
[8]. A possible expansion of this finding to disulfide-free
immunoglobulins in general would open up new possibili-
ties in antibody engineering.
Materials and methods
Materials
The urea used in the denaturation experiments was ultra pure urea
‘enzyme grade’ purchased from BRL, Gaithersburg, MD 20877, USA.
All other reagents were of analytical grade. DNA sequencing was per-
formed using Sequenase (version 2.0) from United States Biochemi-
cal Corp, Cleveland, Ohio, USA. Restriction enzymes and other DNA
modifying enzymes were purchased from Boehringer Mannheim Corpo-
ration or MBI Fermentas, Vilnius 2028, Lithuania. Oligonucleotides
were synthesized using an Applied Biosystems 380B oligonucleotide
synthesizer.
Genetic engineering, production and purification of REIv
variants
Construction of vectors pHKREI, pHKREI-Y32H and pHKREI-
C23V/Y32H has been described elsewhere [8,10]. The introduction of
the mutations leading to amino acid substitutions T39K, Y71F, F73L,
Y71F/F73L and C88V was performed by oligonucleotide-directed
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mutagenesis [24] using the oligonucleotide REI-T39K (5′-pCG-
GAGCTTTACCTGGCTTCTGCTGGTACC-3′), REI-Y71F (5′-pGATA
GTGAAAGTGAAGTCAGTACCAGAACCAGAACC-3′), REI-F73L (5′-
pGAGCTGATAGTCAGAGTGTAGTCAGTACCAGAACCAG-3′), REI-
Y71F/F73L (5′-pGTGAGCTGATAGTCAGAGTGAAGTCAGTACCAG
AACCAGAACC-3′), and REI-C88V (5′-pCTGGTACTGCTGAACG-
TAGTAAGTCGC-3′), respectively. Vector pHKREI-C23V/Y32H/C88V
was constructed by ligation of the 4.3 kb XhoI/XbaI fragment of
pHKREI-C23V/Y32H and the 1.5 kb XhoI/XbaI fragment of pHKREI-
C88V. Vectors pHKREI-C23V and pHKREI-C23V/T39K were con-
structed by ligation of the 5.6 kb NheI/NruI fragment of
pHKREI-C23V/Y32H and the 0.2 kb NheI/NruI fragment of pHKREI
and pHKREI-T39K, respectively. The codon T39K mutation was com-
bined with the Y71F, F73L and Y71F/F73L mutation, respectively, by
replacing the 1.5 kb XhoI/XbaI fragment of pHKREI-T39K by that from
the respective rei genes of pHKREI-Y71F, pHKREI-F73L and pHKREI-
Y71F/F73L, respectively. The nucleotide sequence of all variant rei
genes was confirmed by nucleotide sequence analysis [25]. All other
recombinant DNA techniques followed standard protocols [26]. Pro-
duction and purification of REIv variants was performed as described
previously [8,10].
Crystal structure determination of REIv-T39K
Suitable crystals were grown in sitting drops out of a 10 mg ml–1 solu-
tion of the protein in 50 mM potassium phosphate pH 7, using 20%
PEG 8000 in 0.1 M Hepes buffer, pH 7, as a precipitant. A 0.4 × 0.2 ×
0.05 mm triclinic crystal a = 35.4, b = 40.1, c = 43.1 (Å),  = 66.9,  =
85.4, 	 = 73.8 (°) was mounted in a sealed capillary; room temperature
synchrotron data were collected to 1.7 Å resolution at EMBL-Hamburg,
on the BW7B wiggler beamline using a MAR image-plate scanner.
Data were processed using the program DENZO [27]. The structure
was solved by molecular replacement, using the program AMoRE [28]
with the structure of wild-type REIv as a search fragment [12]. Struc-
ture refinement was performed with the program SHELXL [29]. Further
details of the structure refinement will be published elsewhere.
Reversible urea denaturation
Reversible unfolding of REIv variants was measured essentially as
described [8,13] by following the change of tryptophan fluorescence
upon urea denaturation using a Hitachi F-4500 fluorescence spec-
trophotometer. The measurements were performed at 25°C at a
protein concentration of 1 M. Two sets of wavelength were used
alternatively: excitation at 295 nm, emission at 350 nm (proteins with
the disulfide bridge) and, respectively, excitation at 280 nm, emission
at 330 nm (proteins without a disulfide bridge). 
Analysis of urea denaturation curves
The theoretical basis for the data analysis of urea denaturation curves
has been described [13,20,30–32]. The determination of the [urea]1/2
value, the concentration of urea at which 50% of the protein is
unfolded, was found to be more accurate than the determination of the
free energy of unfolding in the absence of urea (GUH2O) which has
been used in previous studies [8,13]. In this study, therefore, the data
were fitted to equation 1 [32] applying a nonlinear regression analysis
program, operating iteratively according to the least-squares method
(Marquardt–Levenberg algorithm [33]; SigmaPlot; Jandel Scientific)
which gives the values and the calculated standard errors for individual
experimental measurements of [urea]1/2 and m.
Fobs=a[urea]+b–(a[urea]+b–(c[urea]–d))exp{[m([urea]–[urea]1/2)]/RT}
{1+exp[(m([urea]–[urea]1/2))/RT]}
(1)
where Fobs is the fluorescence at the given [urea], a and c are the
slopes and b and d are the intercepts of the baselines at low and high
urea concentration and m is the slope of the transition. Within any set
of independent experiments performed on one and the same REIv
variant, the calculated [urea]1/2 never differed more than ± 0.12 M and
this difference was at most ± 0.09 M using identical urea and buffer
preparations. Generally, [urea]1/2 values differed not more than
± 0.05 M for different measurements of a particular REIv variant. The
difference in the free energy of unfolding, GU, between two REIv
variants was calculated as: 
GU[urea]1/2 = 〈m〉 [urea]1/2 (2)
where 〈m〉 is the average value of m for a set of REIv proteins (compare
references [34,35]) and [urea]1/2 = [urea]1/2 – [urea]′1/2 (the differ-
ence in the value of [urea]1/2 between two REIv variants). The m value
cannot be determined as precisely as the [urea]1/2 value, but the varia-
tions of the m value for all mutants studied thus far were in the range of
the variations for different experimental measurements performed over
a period of time for the individual proteins wild-type REIv and REIv-
L94H [13]. REIv-L94H gave the largest variations of m values. These
varied in six different experimental measurements from 5.64 to
8.42 kJ mol–1 M–1 yielding a mean value of 7.30 kJ mol–1 M–1 and a
standard error of ± 0.41 kJ mol–1 M–1. Thus, the differences of m values
of wild-type REIv and mutant REIv proteins are within the error margins
of the method. Hence, it is valid to calculate a mean value of m from the
data of all measurements. Using this mean value of m obtained from a
large number of experiments allows calculation of GU[urea]1/2 with low
standard error. 
Since the m value is dependent on the sum of the effects of the coop-
erativity of the transition and the exposure of the denatured state to
solvent relative to the native state, we divided the REIv variants into
three groups of independently averaged m values: REIv variants with an
intact disulfide bridge, REIv variants with a reduced disulfide bridge,
and REIv variants with a C23V substitution, which surprisingly dis-
played m values that were similar to those of the REIv variants with
intact disulfide bridge. 〈m〉 values (standard errors are given in paren-
thesis) for the three different groups of REIv variants were: REIv variants
with disulfide bridge, 6.57 (± 0.10) kJ mol–1 M–1; REIv variants with
reduced disulfide bridge, 7.42 (± 0.31) kJ mol–1 M–1; REIv variants with
C23V amino acid exchange, 6.51 (± 0.21) kJ mol–1 M–1. These values
were calculated from 69, 23 and 6 individual experimental measure-
ments, respectively. GU[urea]1/2 for the comparison of free energies of
unfolding between proteins of different groups were calculated as:
GU[urea]1/2 = 〈m〉 [urea]1/2 – 〈m〉′ [urea]′1/2 (3)
The standard errors for parameters m and [urea]1/2 obtained from the
nonlinear regression analysis are indicated if the stability of the respec-
tive protein was measured only once by urea-induced unfolding. Having
two or more individual experimental measurements, the standard error
of the mean is given which was calculated as described [32].
Circular dichroism measurements
Far UV circular dichroism spectra were recorded in 0.01 M potassium
phosphate buffer at pH 7.5 at 25°C using a Jasco J720 spectropo-
larimeter. Measurements were performed in a cell having a 0.02 cm
light path at protein concentrations of ~ 40 M for measurements in
0 M urea and of ~ 20 M for measurements in 8 M urea. All spectra
were measured 10 times and averaged. The results are expressed as
residue ellipticity, [
]MRW [18], which is defined as [
]MRW =(
 × 100
× Mr)/(c × d × NA). 
 is the measured ellipticity in degrees, c is the
protein concentration in mg ml–1, d is the path length in cm, NA is the
number of amino acids per protein and Mr and MRW are the protein
molecular weight and the mean residue weight, respectively.
Small zone gel filtration measurements
The molecular mass distribution of REIv variants was examined at differ-
ent protein concentrations by gel filtration exactly as described [13]. A
Superose 12 column (10 × 300 mm) was connected to a Pharmacia
FPLC chromatography system and run at 0.5 ml min–1 at 4°C. The
buffer was 20 mM potassium phosphate, pH 7.0, 0.1 M NaCl.
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Immunochemical detection of -lactamase
For immunochemical detection of -lactamase/REIv fusion proteins,
50 ml cultures of E. coli strain KS474 [36] harboring a pHKREI deriva-
tive were grown at 25°C for 20 h and periplasmic proteins were iso-
lated as described [10]. These were resolved by 15% SDS-PAGE and
analyzed by western blotting using a polyclonal rabbit anti--lactamase
serum (5′ → 3′ Inc, Boulder, CO, USA). Reactive proteins were visual-
ized using an alkaline phosphatase-conjugated goat anti rabbit second
antibody (Sigma, St Louis, MO, USA).
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